MicroRNA function in megakaryocytes

References

• Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006;20:515–524.
   PubMed Web of Science ®Google Scholar
• Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010;11:597–610.
   PubMed Web of Science ®Google Scholar
• Raghuwanshi S, Karnati HK, Sarvothaman S, Gutti U, Saladi RG, Tummala PR, Gutti RK. microRNAs: key Players in Hematopoiesis. Adv Exp Med Biol 2015;887:171–211.
   PubMed Web of Science ®Google Scholar
• Raslova H, Roy L, Vourc'h C, Le Couedic JP, Brison O, Metivier D, Feunteun J, Kroemer G, Debili N, Vainchenker W. Megakaryocyte polyploidization is associated with a functional gene amplification. Blood 2003;101(2):541–544.
   PubMed Web of Science ®Google Scholar
• Edelstein LC, McKenzie SE, Shaw C, Holinstat MA, Kunapuli SP, Bray PF. MicroRNAs in platelet production and activation. J Thromb Haemost 2013;11(Suppl 1):340–350.
   PubMed Web of Science ®Google Scholar
• Rowley JW, Chappaz S, Corduan A, Chong MM, Campbell R, Khoury A, Manne BK, Wurtzel JG, Michael JV, Goldfinger LE, et al. Dicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets. Blood 2016;127(14):1743–1751.
   PubMed Web of Science ®Google Scholar
• Garzon R, Pichiorri F, Palumbo T, Iuliano R, Cimmino A, Aqeilan R, Volinia S, Bhatt D, Alder H, Marcucci G, et al. MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci U S A 2006;103(13):5078–5083.
   PubMed Web of Science ®Google Scholar
• Lu J, Guo S, Ebert BL, Zhang H, Peng X, Bosco J, Pretz J, Schlanger R, Wang JY, Mak RH, et al. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell 2008;14:843–853.
   PubMed Web of Science ®Google Scholar
• Romania P, Lulli V, Pelosi E, Biffoni M, Peschle C, Marziali G. MicroRNA 155 modulates megakaryopoiesis at progenitor and precursor level by targeting Ets-1 and Meis1 transcription factors. Br J Haematol 2008;143:570–580.
   PubMed Web of Science ®Google Scholar
• Navarro F, Gutman D, Meire E, Caceres M, Rigoutsos I, Bentwich Z, Lieberman J. miR-34a contributes to megakaryocytic differentiation of K562 cells independently of p53. Blood 2009;114:2181–2192.
   PubMed Web of Science ®Google Scholar
• Felli N, Pedini F, Romania P, Biffoni M, Morsilli O, Castelli G, Santoro S, Chicarella S, Sorrentino A, Peschle C, et al. MicroRNA 223-dependent expression of LMO2 regulates normal erythropoiesis. Haematologica 2009;94(4):479–486.
   PubMed Web of Science ®Google Scholar
• Bianchi E, Bulgarelli J, Ruberti S, Rontauroli S, Sacchi G, Norfo R,Pennucci V, Zini R, Salati S, Prudente Z, et al. MYB controls erythroid versus megakaryocyte lineage fate decision through the miR-486-3p-mediated downregulation of MAF. Cell Death Differ 2015;22(12):1906–1921.
   PubMed Web of Science ®Google Scholar
• Labbaye C, Spinello I, Quaranta MT, Pelosi E, Pasquini L, PetrucciE, Biffoni M, Nuzzolo ER, Billi M, Foà R, et al. A three-step pathway comprising PLZF/miR-146a/CXCR4 controls megakaryopoiesis. Nat Cell Biol 2008;10:788–801.
   PubMed Web of Science ®Google Scholar
• Chapnik E, Rivkin N, Mildner A, Beck G, Pasvolsky R, Metzl-Raz E, Birger Y, Amir G, Tirosh I, Porat Z, et al. miR-142 orchestrates a network of actin cytoskeleton regulators during megakaryopoiesis. eLife. 2014;3:e01964.
   PubMed Web of Science ®Google Scholar
• Bluteau O, Langlois T, Rivera-Munoz P, Favale F, Rameau P, Meurice G, Dessen P, Solary E, Raslova H, Mercher T, et al. Developmental changes in human megakaryopoiesis. J Thromb Haemost 2013;11:1730–1741.
   PubMed Web of Science ®Google Scholar
• Ferrer-Marin F, Gutti R, Liu ZJ, Sola-Visner M. MiR-9 contributes to the developmental differences in CXCR-4 expression in human megakaryocytes. J Thromb Haemost 2014;12(2):282–285.
   Web of Science ®Google Scholar
• Raghuwanshi S, Gutti U, Kandi R, Gutti RK. MicroRNA-9 promotes cell proliferation by regulating RUNX1 expression in human megakaryocyte development. Cell Prolif 2018;51(1):e12414.
   Google Scholar
• Undi RB, Gutti U, Gutti RK. Role of let-7b/Fzd4 axis in mitochondrial biogenesis through wnt signaling: in neonatal and adult megakaryocytes. Int J Biochem Cell Biol 2016;79:61–68.
   PubMed Web of Science ®Google Scholar
• Kandi R, Gutti U, Undi R, Sahu I, Gutti RK. Understanding thrombocytopenia: physiological role of microRNA in survival of neonatal megakaryocytes. J Thromb Thrombolysis 2015;40(3):310–316.
   PubMed Web of Science ®Google Scholar
• Emambokus N, Vegiopoulos A, Harman B, Jenkinson E, Anderson G, Frampton J. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of cMyb. Embo J 2003;22:4478–4488.
   PubMed Web of Science ®Google Scholar
• Barroga CF, Pham H, Kaushansky K. Thrombopoietin regulates c-Myb expression by modulating micro RNA 150 expression. Exp Hematol 2008;36:1585–1592.
   PubMed Web of Science ®Google Scholar
• Adams BD, Guo S, Bai H, Guo Y, Megyola CM, Cheng J, HeydariK, Xiao C, Reddy EP, Lu J. An in vivo functional screen uncovers miR-150-mediated regulation of hematopoietic injury response. Cell Rep 2012;2(4):1048–1060.
   Web of Science ®Google Scholar
• Georgantas RW, Hildreth R, Morisot S, Alder J, Liu CG, Heimfeld S, Calin GA, Croce CM, Civin CI. CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci USA 2007;104:2750–2755.
   PubMed Web of Science ®Google Scholar
• Jackers P, Szalai G, Moussa O, Watson DK. Ets-dependent regulation of target gene expression during megakaryopoiesis. J Biol Chem 2004;279:52183–52190.
   PubMed Web of Science ®Google Scholar
• Minami T, Tachibana K, Imanishi T, Doi T. Both Ets-1 and GATA-1 are essential for positive regulation of platelet factor 4 gene expression. Eur J Biochemistry 1998;258:879–889.
   PubMedGoogle Scholar
• Okada Y, Nagai R, Sato T, Matsuura E, Minami T, Morita I, Doi T. Homeodomain proteins MEIS1 and PBXs regulate the lineage-specific transcription of the platelet factor 4 gene. Blood 2003;101:4748–4756.
   PubMed Web of Science ®Google Scholar
• Hisa T, Spence SE, Rachel RA, Fujita M, Nakamura T, Ward JM, Devor-Henneman DE, Saiki Y, Kutsuna H, Tessarollo L, et al. Hematopoietic, angiogenic and eye defects in Meis1 mutant animals. The EMBO Journal 2004;23(2):450–459.
   Web of Science ®Google Scholar
• Norfo R, Zini R, Pennucci V, Bianchi E, Salati S, Guglielmelli P,Bogani C, Fanelli T, Mannarelli C, Rosti V, et al. miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155/JARID2 axis in abnormal megakaryopoiesis. Blood 2014;124(13):e21–e32.
   PubMed Web of Science ®Google Scholar
• O'Connell RM, Rao DS, Chaudhuri AA, Boldin MP, Taganov KD, Nicoll J, Paquette RL, Baltimore D. Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 2008;205:585–594.
   PubMed Web of Science ®Google Scholar
• Ichimura A, Ruike Y, Terasawa K, Shimizu K, Tsujimoto G. MicroRNA-34a inhibits cell proliferation by repressing mitogen-activated protein kinase kinase 1 during megakaryocytic differentiation of K562 cells. Mol Pharmacol 2010;77:1016–1024.
   PubMed Web of Science ®Google Scholar
• Yuan JY, Wang F, Yu J, Yang GH, Liu XL, Zhang JW. MicroRNA-223 reversibly regulates erythroid and megakaryocytic differentiation of K562 cells. J Cell Mol Med 2009;13(11–12):4551–4559.
   PubMed Web of Science ®Google Scholar
• Opalinska JB, Bersenev A, Zhang Z, Schmaier AA, Choi J, Yao Y, D'Souza J, Tong W, Weiss MJ. MicroRNA expression in maturing murine megakaryocytes. Blood 2010;116(23):e128–138.
   Web of Science ®Google Scholar
• Starczynowski DT, Kuchenbauer F, Argiropoulos B, Sung S, Morin R, Muranyi A, Hirst M, Hogge D, Marra M, Wells RA, et al. Identification of miR-145 and miR-146a as mediators of the 5q-syndrome phenotype. Nat Med 2010;16(1):49–58.
   PubMed Web of Science ®Google Scholar
• Starczynowski DT, Kuchenbauer F, Wegrzyn J, Rouhi A, Petriv O, Hansen CL, Humphries RK, Karsan A. MicroRNA-146a disrupts hematopoietic differentiation and survival. Exp Hematol 2011;39(2):167–178.e4.
   PubMed Web of Science ®Google Scholar
• Ben-Ami O, Pencovich N, Lotem J, Levanon D, Groner Y. A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis. Proc Natl Acad Sci U S A 2009;106:238–243.
   PubMed Web of Science ®Google Scholar
• Li X, Zhang J, Gao L, McClellan S, Finan MA, Butler TW, Owen LB, Piazza GA, Xi Y. MiR-181 mediates cell differentiation by interrupting the Lin28 and let-7 feedback circuit. Cell Death Differ 2012;19:378–386.
   PubMed Web of Science ®Google Scholar
• Girardot M, Pecquet C, Boukour S, Knoops L, Ferrant A,Vainchenker W, Giraudier S, Constantinescu SN. miR-28 is a thrombopoietin receptor targeting microRNA detected in a fraction of myeloproliferative neoplasm patient platelets. Blood 2010;116:437–445.
   PubMed Web of Science ®Google Scholar
• Zhang L, Li X, Ke Z, Huang L, Liang Y, Wu J, Zhang X, Chen Y, Zhang H, Luo X. MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia. Cancer Cell Int 2013;13(1):110.
   PubMedGoogle Scholar
• Kandi R, Undi R, Gutti RK. MiR-125b regulates cell proliferation and survival in neonatal megakaryocytes. Ann Hematol 2014;93(6):1065–1066.
   PubMed Web of Science ®Google Scholar
• Guerriero R, Mattia G, Testa U, Chelucci C, Macioce G, CasellaI, Samoggia P, Peschle C, Hassan HJ. Stromal cell-derived factor 1alpha increases polyploidization of megakaryocytes generated by human hematopoietic progenitor cells. Blood 2001;97:2587–2595.
   PubMed Web of Science ®Google Scholar
• Avecilla ST, Hattori K, Heissig B, Tejada R, Liao F, Shido K, JinDK, Dias S, Zhang F, Hartman TE, et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 2004;10:64–71.
   PubMed Web of Science ®Google Scholar
• Michaud J, Wu F, Osato M, Cottles GM, Yanagida M, Asou N, Shigesada K, Ito Y, Benson KF, Raskind WH, et al. In vitro analyses of known and novel RUNX1/AML1 mutations in dominant familial platelet disorder with predisposition to acute myelogenous leukemia: implications for mechanisms of pathogenesis. Blood 2002;99(4):1364–1372.
   Web of Science ®Google Scholar
• Growney JD, Shigematsu H, Li Z, Lee BH, Adelsperger J, Rowan R, Curley DP, Kutok JL, Akashi K, Williams IR, et al. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood 2005;106:494–504.
   PubMed Web of Science ®Google Scholar
• Jacob B, Osato M, Yamashita N, Wang CQ, Taniuchi I, Littman DR, Asou N, Ito Y. Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis. Blood 2010;115(8):1610–1620.
   PubMed Web of Science ®Google Scholar